XML 77 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Tables)
12 Months Ended
Jul. 31, 2012
Share-Based Compensation Expense

The following table presents share-based compensation expense included in the Company’s consolidated statements of operations for the years ended July 31, 2012, 2011 and 2010 (in thousands):

 

     July 31,  
     2012      2011      2010  

Cost of product revenue

   $ 164       $ 185       $ 237   

Cost of service revenue

     454         281         272   

Research and development

     1,519         848         1,092   

Sales and marketing

     749         719         924   

General and administrative

     903         718         765   
  

 

 

    

 

 

    

 

 

 

Net compensation expense

   $ 3,789       $ 2,751       $ 3,290   
  

 

 

    

 

 

    

 

 

 
The Fair Value of Each Option Grant

The fair value of each option grant was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

 

     July 31,  
     2012     2011     2010  

Expected option term(1)

     5.8 years        6.1 years        5.2 years   

Expected volatility factor (2)

     46.9     44.5     39.2

Risk-free interest rate (3)

     1.3     2.4     2.2

Expected annual dividend yield (4)

     0.0     0.0     0.0
Stock Option Activity

Stock option activity under all of the Company’s stock plans during the year ended July 31, 2012 is summarized as follows:

 

     Number of
Shares
    Weighted
Average

Exercise
Price
     Weighted
Average
Contractual
Term
(Years)
 

Outstanding at July 31, 2011 .

     2,993,840      $ 20.33         5.59   
  

 

 

   

 

 

    

 

 

 

Options granted .

     17,875        18.37      

Options exercised .

     (140,485     17.40      

Options canceled .

     (729,940     21.91      
  

 

 

   

 

 

    

Outstanding at July 31, 2012 .

     2,141,290      $ 19.96         6.03   
  

 

 

   

 

 

    

 

 

 

Options vested and expected to vest

     2,098,875      $ 19.95         5.97   
  

 

 

   

 

 

    

 

 

 

Options exercisable at end of period

     1,524,776      $ 19.80         5.06